Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
This webinar, focused on challenging cases in metastatic breast cancer, was moderated by Ashkan Lashkari, MD, oncologist at Wellness Oncology, California, and included expert panelists Rebecca A. Shatsky,…
Tufia C. Haddad, MD, an oncologist at Mayo Clinic, Rochester, Minnesota, discusses what to expect before, during, and after initial treatment for metastatic breast cancer. Dr Haddad emphasizes…
Join Dr. Dorothy Fink and Dr. Arun Karlamangla for a Q&A session during National Women’s Health Week, focusing on optimizing health in perimenopause, menopause, and beyond. Dr. Fink,…
Michael Hochman, MD, MPH, board certified general internist at USC’s Keck School of Medicine, cofounder of Updates in Slow Medicine, and host of the Healthy Skeptic, MD podcast,…
Adam Schlifke, MD, MBA, practicing anesthesiologist and Clinical Assistant Professor of Anesthesiology, Perioperative and Pain Medicine at Stanford Medicine, has started a company with a unique model that will…
Adam Schlifke, MD, MBA, practicing anesthesiologist and Clinical Assistant Professor of Anesthesiology, Perioperative and Pain Medicine at Stanford Medicine, has created a process for quickly and effectively converting the…
